{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:59:30Z","timestamp":1777535970604,"version":"3.51.4"},"reference-count":39,"publisher":"National Institute of Industrial Health","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ind Health","INDUSTRIAL HEALTH"],"published-print":{"date-parts":[[2025]]},"DOI":"10.2486\/indhealth.2024-0025","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T22:10:14Z","timestamp":1715897414000},"page":"14-28","source":"Crossref","is-referenced-by-count":6,"title":["Mesothelioma carcinogenesis of chrysotile and forsterite compared and          validated by intraperitoneal injection in rat"],"prefix":"10.2486","volume":"63","author":[{"given":"Ayako","family":"TAKATA","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine, St. Marianna University School of              Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"YAMAUCHI","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, St. Marianna University School of              Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotsugu","family":"YAMASHITA","sequence":"additional","affiliation":[{"name":"Nozawa Technical Institute, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"AMINAKA","sequence":"additional","affiliation":[{"name":"Faculty of Food Culture, Kurashiki Sakuyo University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"HITOMI","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, St. Marianna University School of              Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"TOYA","sequence":"additional","affiliation":[{"name":"Organization of Occupational Health and Safety, National Institute of              Occupational Safety and Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"KOHYAMA","sequence":"additional","affiliation":[{"name":"Organization of Occupational Health and Safety, National Institute of              Occupational Safety and Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Selikoff              IJ, Lee              DHK (1978)          Asbestos and disease. 241\u2013336, Academic Press, New York.","DOI":"10.1016\/B978-0-12-636050-9.50015-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Alpert              N, van Gerwen              M, Taioli              E (2020)            Epidemiology of mesothelioma in the 21st century in Europe and the United            States, 40 years after restricted\/banned asbestos use. Transl            Lung Cancer Res          9Suppl 1, S28\u201338.","DOI":"10.21037\/tlcr.2019.11.11"},{"key":"3","unstructured":"3) US-EPA. Final risk          evaluation for asbestos, part 1: chrysotile asbestos. https:\/\/www.epa.gov\/assessing-and-managing-chemicals-under-tsca\/final-risk-evaluation-asbestos-part-1-chrysotile.          Accessed December 15, 2023."},{"key":"4","unstructured":"4) World Health Organization (WHO)            Chemical Safety and Health\u2014Asbestos 2020. https:\/\/www.who.int\/teams\/environment-climate-change-and-health\/chemical-safety-and-health\/health-impacts\/chemicals\/asbestos.          Accessed December 15, 2023."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Frank              AL, Joshi              TK (2014)            The global spread of asbestos. Ann Glob            Health          80, 257\u201362.","DOI":"10.1016\/j.aogh.2014.09.016"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Spasiano              D, Pirozzi              F (2017)            Treatments of asbestos containing wastes. J            Environ Manage          204, 82\u201391.","DOI":"10.1016\/j.jenvman.2017.08.038"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Marian              NM, Giorgetti              G, Magrini              C, Capitani              GC,                Galimberti              L, Cavallo              A, Salvini              R, Vanneschi              C, Viti              C (2021)            From hazardous asbestos containing wastes (ACW) to new secondary raw            material through a new sustainable inertization process: a multimethodological            mineralogical study. J Hazard Mater          413, 125419.","DOI":"10.1016\/j.jhazmat.2021.125419"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Bolan              S, Kempton              L, McCarthy              T, Wijesekara              H,                Piyathilake              U, Jasemizad              T, Padhye              LP, Zhang              T, Rinklebe              J, Wang              H, Kirkham              MB, Siddique              KHM, Bolan              N (2023)            Sustainable management of hazardous asbestos-containing materials:            containment, stabilization and inertization. Sci Total            Environ          881, 163456.","DOI":"10.1016\/j.scitotenv.2023.163456"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Churg              A (1988)            Chrysotile, tremolite, and malignant mesothelioma in man.            Chest          93, 621\u20138.","DOI":"10.1378\/chest.93.3.621"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nicholson              WJ (2001)            The carcinogenicity of chrysotile asbestos\u2014a review.            Ind Health          39, 57\u201364.","DOI":"10.2486\/indhealth.39.57"},{"key":"11","unstructured":"11) IARC (2012)          IARC monographs on the evaluation of carcinogenic risks to humans. Arsenic, metals,          fibres, and dusts. Volume 100C, A review of human carcinogens. Asbestos. 219\u201394,          Lyon."},{"key":"12","unstructured":"12) World Health Organization (WHO) Chrysotile          asbestos. 2014. https:\/\/www.who.int\/publications\/i\/item\/9789241564816. Accessed December 15,          2023."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Suzuki              Y, Kohyama              N (1984)            Malignant mesothelioma induced by asbestos and zeolite in the mouse            peritoneal cavity. Environ Res          35, 277\u201392.","DOI":"10.1016\/0013-9351(84)90136-1"},{"key":"14","unstructured":"14) Davis              JM, Addison              J, Bolton              RE, Donaldson              K, Jones              AD (1986)            Inhalation and injection studies in rats using dust samples from            chrysotile asbestos prepared by a wet dispersion process. Br J            Exp Pathol          67, 113\u201329."},{"key":"15","unstructured":"15) Davis              JM, Jones              AD (1988)            Comparisons of the pathogenicity of long and short fibres of chrysotile            asbestos in rats. Br J Exp Pathol          69, 717\u201337."},{"key":"16","unstructured":"16) Davis              JM, Bolton              RE, Miller              BG, Niven              K (1991)            Mesothelioma dose response following intraperitoneal injection of mineral            fibres. Int J Exp Pathol          72, 263\u201374."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Wallis              SL, Emmett              EA, Hardy              R, Casper              BB, Blanchon              DJ, Testa              JR, Menges              CW, Gonneau              C, Jerolmack              DJ, Seiphoori              A, Steinhorn              G, Berry              TA (2020)            Challenging global waste management\u2014bioremediation to detoxify            asbestos. Front Environ Sci          8, 20.","DOI":"10.3389\/fenvs.2020.00020"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Carlin              DJ, Larson              TC, Pfau              JC, Gavett              SH, Shukla              A, Miller              A, Hines              R (2015)            Current research and opportunities to address environmental asbestos            exposures. Environ Health Perspect          123, A194\u20137.","DOI":"10.1289\/ehp.1409662"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Hayashi              H (1974)            Cytotoxicity of heated chrysotile. Environ Health            Perspect          9, 267\u201370.","DOI":"10.1289\/ehp.749267"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Valentine              R, Chang              MJ, Hart              RW, Finch              GL, Fisher              GL (1983)            Thermal modification of chrysotile asbestos: evidence for decreased            cytotoxicity. Environ Health Perspect          51, 357\u201368.","DOI":"10.1289\/ehp.8351357"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Takata              A, Yamauchi              H, Toya              T, Aminaka              M, Shinohara              Y, Kohyama              N, Yoshida              K (2009)            Forsterite exposure causes less oxidative DNA damage and lung injury than            chrysotile exposure in rats. Inhal Toxicol          21, 739\u201346.","DOI":"10.1080\/08958370802492399"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Takata              A, Yamauchi              H, Toya              T,                Miyamoto-Kohno              S, Iwatatsu              Y, Teranaka              I, Aminaka              M, Yamashita              K, Kohyama              N (2011)            Effectiveness of serum megakaryocyte potentiating factor in evaluating            the effects of chrysotile and its heated products on respiratory organs.            Toxicol Appl Pharmacol          252, 123\u20139.","DOI":"10.1016\/j.taap.2010.09.026"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Bolton              RE, Davis              JMG,                Donaldson              K, Wright              A (1982)            Variations in the carcinogenicity of mineral fibres.            Ann Occup Hyg          26, 569\u201382.","DOI":"10.1016\/B978-0-08-026838-5.50046-5"},{"key":"24","unstructured":"24) Le                Bouffant              L, Bruy\u00e8re              S, Daniel              H, Martin              JC, Henin              JP, Tichoux              G, Nattier              P (1983)            Influence d\u2019un traitement thermique des fibres de chrysotile sur leur            comportement dans le poumon. Pollut Atmospherique          97, 44\u20139 (in          French)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Marczynski              B, Rozynek              P, Kraus              T, Schl\u00f6sser              S, Raithel              HJ, Baur              X (2000)            Levels of 8-hydroxy-2\u2032-deoxyguanosine in DNA of white blood cells from            workers highly exposed to asbestos in Germany. Mutat            Res          468, 195\u2013202.","DOI":"10.1016\/S1383-5718(00)00053-X"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Marczynski              B, Kraus              T, Rozynek              P, Raithel              HJ, Baur              X (2000)            Association between 8-hydroxy-2\u2032-deoxyguanosine levels in DNA of workers            highly exposed to asbestos and their clinical data, occupational and non-occupational            confounding factors, and cancer. Mutat Res          468, 203\u201312.","DOI":"10.1016\/S1383-5718(00)00054-1"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yoshida              R, Ogawa              Y, Shioji              I, Yu              X, Shibata              E, Mori              I, Kubota              H, Kishida              A, Hisanaga              N (2001)            Urinary 8-oxo-7, 8-dihydro-2\u2032-deoxyguanosine and biopyrrins levels among            construction workers with asbestos exposure history. Ind            Health          39, 186\u20138.","DOI":"10.2486\/indhealth.39.186"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Yang              HY (2019)            Prediction of pneumoconiosis by serum and urinary biomarkers in workers            exposed to asbestos-contaminated minerals. PLoS One          14, e0214808.","DOI":"10.1371\/journal.pone.0214808"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Maeda              M, Hino              O (2006)            Molecular tumor markers for asbestos-related mesothelioma: serum            diagnostic markers. Pathol Int          56, 649\u201354.","DOI":"10.1111\/j.1440-1827.2006.02024.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Hagiwara              Y, Hamada              Y, Kuwahara              M, Maeda              M, Segawa              T, Ishikawa              K, Hino              O (2008)            Establishment of a novel specific ELISA system for rat N- and            C-ERC\/mesothelin. Rat ERC\/mesothelin in the body fluids of mice bearing            mesothelioma. Cancer Sci          99, 666\u201370.","DOI":"10.1111\/j.1349-7006.2008.00731.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Chung              CT, Santos              GC, Hwang              DM, Ludkovski              O, Pintilie              M, Squire              JA, Tsao              MS (2010)            FISH assay development for the detection of p16\/CDKN2A deletion in            malignant pleural mesothelioma. J Clin Pathol          63, 630\u20134.","DOI":"10.1136\/jcp.2010.076794"},{"key":"32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s12885-019-5652-y","volume":"19","year":"2019","unstructured":"32) Kettunen              E, Savukoski              S, Salmenkivi              K, B\u00f6hling              T, Vanhala              E, Kuosma              E, Anttila              S, Wolff              H (2019)            CDKN2A copy number and p16 expression in malignant pleural mesothelioma            in relation to asbestos exposure. BMC Cancer          19, 507.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Greaves              P, Chouinard              L, Ernst              H,                Mecklenburg              L,                Pruimboom-Brees              IM, Rinke              M,                Rittinghausen              S, Thibault              S, Von                Erichsen              J, Yoshida              T (2013)            Proliferative and non-proliferative lesions of the rat and mouse soft            tissue, skeletal muscle and mesothelium. J Toxicol            Pathol          26Suppl, 1S\u201326S.","DOI":"10.1293\/tox.26.1S"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Kasai              H (2003)            A new automated method to analyze urinary 8-hydroxydeoxyguanosine by a            high-performance liquid chromatography-electrochemical detector system.            J Radiat Res          44, 185\u20139.","DOI":"10.1269\/jrr.44.185"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Jiang              L, Nagai              H, Ohara              H, Hara              S, Tachibana              M, Hirano              S, Shinohara              Y, Kohyama              N, Akatsuka              S, Toyokuni              S (2008)            Characteristics and modifying factors of asbestos-induced oxidative DNA            damage. Cancer Sci          99, 2142\u201351.","DOI":"10.1111\/j.1349-7006.2008.00934.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Jiang              L, Akatsuka              S, Nagai              H, Chew              SH, Ohara              H, Okazaki              Y, Yamashita              Y, Yoshikawa              Y, Yasui              H, Ikuta              K, Sasaki              K, Kohgo              Y, Hirano              S, Shinohara              Y, Kohyama              N, Takahashi              T, Toyokuni              S (2012)            Iron overload signature in chrysotile-induced malignant            mesothelioma. J Pathol          228, 366\u201377.","DOI":"10.1002\/path.4075"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Sch\u00fcrkes              C, Brock              W, Abel              J, Unfried              K (2004)            Induction of 8-hydroxydeoxyguanosine by man made vitreous fibres and            crocidolite asbestos administered intraperitoneally in rats.            Mutat Res          553, 59\u201365.","DOI":"10.1016\/j.mrfmmm.2004.06.021"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Shiomi              K, Miyamoto              H, Segawa              T, Hagiwara              Y, Ota              A, Maeda              M, Takahashi              K, Masuda              K, Sakao              Y, Hino              O (2006)            Novel ELISA system for detection of N-ERC\/mesothelin in the sera of            mesothelioma patients. Cancer Sci          97, 928\u201332.","DOI":"10.1111\/j.1349-7006.2006.00246.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Shiomi              K, Hagiwara              Y, Sonoue              K, Segawa              T, Miyashita              K, Maeda              M, Izumi              H, Masuda              K,                Hirabayashi              M, Moroboshi              T, Yoshiyama              T, Ishida              A, Natori              Y, Inoue              A, Kobayashi              M, Sakao              Y, Miyamoto              H, Takahashi              K, Hino              O (2008)            Sensitive and specific new enzyme-linked immunosorbent assay for            N-ERC\/mesothelin increases its potential as a useful serum tumor marker for            mesothelioma. Clin Cancer Res          14, 1431\u20137.","DOI":"10.1158\/1078-0432.CCR-07-1613"}],"container-title":["Industrial Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/indhealth\/63\/1\/63_2024-0025\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T03:24:44Z","timestamp":1737775484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/indhealth\/63\/1\/63_2024-0025\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2486\/indhealth.2024-0025","relation":{},"ISSN":["0019-8366","1880-8026"],"issn-type":[{"value":"0019-8366","type":"print"},{"value":"1880-8026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2024-0025"}}